Quantbot Technologies LP

Position in ABBV — AbbVie Inc.

CIK 1512991 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$116,760

-$2,596,818 QoQ

Shares Held

464

-96.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#4,027

of 4,167 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Quantbot Technologies LP holds $17,451,386 across 9 Drug Manufacturers - General names. ABBV ranks #8 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	128,286	$6,724,752
2	PFE	Pfizer Inc	133,304	$3,209,960
3	LLY	ELI LILLY & Co	2,129	$2,553,586
4	BMY	Bristol Myers Squibb Co	33,000	$1,901,460
5	GILD	Gilead Sciences, Inc.	11,342	$1,432,948
6	NVS	Novartis AG	8,263	$1,294,977
7	AZN	Astrazeneca PLC	1,009	$191,326
8	ABBV	AbbVie Inc. This page	464	$116,760

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$116,760	464	-96.8%	Shares	Sole	2026-08-12
2025-06-30	$2,713,578	14,619	+1296.3%	Shares	Sole	2025-08-13
2024-12-31	$186,051	1,047	+35.8%	Shares	Sole	2025-02-11
2024-09-30	$152,257	771	+53.9%	Shares	Sole	2024-11-13
2023-12-31	$77,639	501	-78.6%	Shares	Sole	2024-02-14
2023-09-30	$349,247	2,343	-76.1%	Shares	Sole	2023-11-07
2023-03-31	$1,561,666	9,799	+526.1%	Shares	Sole	2023-05-12
2022-12-31	$252,919	1,565	-85.1%	Shares	Sole	2023-02-13
2021-09-30	$1,133,066	10,504	-56.3%	Shares	Sole	2021-11-09
2021-06-30	$2,708,203	24,043	+10.5%	Shares	Sole	2021-08-12
2020-12-31	$2,331,584	21,760	+156.8%	Shares	Sole	2021-02-12
2020-09-30	$742,150	8,473	-60.8%	Shares	Sole	2020-11-16
2020-06-30	$2,123,535	21,629	+705.5%	Shares	Sole	2020-08-13
2020-03-31	$204,570	2,685	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.